We are almost there ...
Aurobindo Pharma gets FDA approval for generic equivalent of Xarelto
The anticoagulant drug, which has an estimated US market size of $447 million, is set to be launched in the first quarter of the 2025-26 fiscal.
13 April, 2025•2 min
0
13 April, 2025•2 min
0
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
SUBSCRIBE
Already have an account? Sign In
More in Business
Business
Why foreign universities want a presence in the UAE
A mix of government facilitation, favourable location and rising student demand is seeing global institutions making a beeline for the region.
You may also like
Business
Has Aurobindo Pharma left its wild swings behind?
The Hyderabad-based generics maker has seen its stock scale all-time highs and lows in quick succession. With big plans in place and regulatory heat easing, its roller-coaster days may be over.
Business
Is Aurobindo Pharma the most underrated pharma company?
The Hyderabad-based generics maker is now India’s largest supplier of off-patent medicines to the US.